Bacteria competing with the adhesion and biofilm formation by Staphylococcus aureus
Language English Country United States Media print-electronic
Document type Journal Article
- MeSH
- Anti-Bacterial Agents metabolism pharmacology MeSH
- Antibiosis MeSH
- Bacterial Adhesion drug effects MeSH
- Bacteriocins metabolism pharmacology MeSH
- Biofilms drug effects MeSH
- Culture Media, Conditioned pharmacology MeSH
- Lactobacillus acidophilus growth & development metabolism physiology MeSH
- Humans MeSH
- Plankton growth & development MeSH
- Probiotics MeSH
- Pseudomonas aeruginosa growth & development metabolism physiology MeSH
- Staphylococcus aureus drug effects growth & development physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- Bacteriocins MeSH
- Culture Media, Conditioned MeSH
The activity of antagonistic substances produced by Pseudomonas aeruginosa and Lactobacillus acidophilus against the planktonic and sessile populations of Staphylococcus aureus strains was demonstrated. The strongest effects were caused by probiotic L. acidophilus strain - bacteriocin-like inhibitory substances (BLIS) positive. However, the S. aureus A3 growth, adhesion and biofilm formation was also limited by cell-free supernatant of L. acidophilus H-1 (BLIS negative). Moreover, competitive direct interactions were observed between staphylococci and the above bacteria, which influenced the formation of dualspecies aggregates on the surface.
See more in PubMed
Biochimie. 2002 May-Jun;84(5-6):499-510 PubMed
Appl Environ Microbiol. 1994 Jun;60(6):1867-74 PubMed
Appl Environ Microbiol. 2004 Jul;70(7):4340-8 PubMed
FEMS Immunol Med Microbiol. 2002 Dec 13;34(4):245-53 PubMed
Microbiology (Reading). 2006 Jun;152(Pt 6):1819-1826 PubMed
Am J Clin Nutr. 1999 May;69(5):1035S-1045S PubMed
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):309-14 PubMed
Antimicrob Agents Chemother. 2004 May;48(5):1681-7 PubMed
Folia Microbiol (Praha). 2008;53(1):61-6 PubMed
Trends Microbiol. 2001 Sep;9(9):424-8 PubMed
Nat Rev Microbiol. 2004 Feb;2(2):95-108 PubMed
Infect Immun. 2005 Sep;73(9):6055-63 PubMed
Folia Microbiol (Praha). 2008;53(3):263-9 PubMed
Infect Immun. 2006 Feb;74(2):910-9 PubMed
J Appl Microbiol. 2002;93(2):345-52 PubMed
J Ind Microbiol. 1995 Sep;15(3):248-53 PubMed
Trends Microbiol. 2005 Dec;13(12):589-95 PubMed
Folia Microbiol (Praha). 2006;51(5):381-6 PubMed
Microbes Infect. 2003 Dec;5(15):1357-62 PubMed
Antimicrob Agents Chemother. 2009 Sep;53(9):4028-31 PubMed
Folia Microbiol (Praha). 2008;53(3):189-94 PubMed
